Angiotensin II Completed Phase 4 Trials for Exercise Tolerance / Strength, Muscle / Vasodilation / Bodycomposition / Heart Failure Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT03190304The Effect of Neprilysin (LCZ696) on Exercise Tolerance in Patients With Heart Failure